期刊文献+

预防造影剂肾病的不同水化护理方法探讨 被引量:3

下载PDF
导出
摘要 目的探讨不同的水化护理方法对预防造影剂肾病发生的有效性。方法将2006年3月至2009年3月对本院共552例行冠状动脉介入诊断或治疗的患者随机分为低渗组、等渗组和碳酸氢钠组三组,于术前12h至术后12h分别静滴低渗盐水、等渗盐水及碳酸氢钠,观察术前1d、术后24h、72h血清肌酐、肌酐清除率的变化。结果造影后72h血清肌酐上升幅度碳酸氢钠组低于低渗组、等渗组,差异具有统计学意义。结论碳酸氢钠在预防造影剂肾病的发生方面比低渗盐水及等渗盐水具有更为良好的郊果。
出处 《中国现代药物应用》 2010年第4期194-196,共3页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献9

  • 1Mehran R. Contrast induced nephropathy remains a serious complication of PCI. J Interv Cardiol,2007,20 (3) :236-240.
  • 2Levy EM,Viscoli CM,Horwitz RI. The effect of acute renal failure on mortality :Acohort analysis. JAMA, 1996,275 ( 19 ) : 1489-1494.
  • 3邹古明,颜红兵.造影剂肾病的诊断与治疗现状[J].中国介入心脏病学杂志,2005,13(3):194-196. 被引量:78
  • 4Idee J, Boehm J, Prigent P, et al. Role of Apoptosis in the pathogenesis of Contrast M edia-induced Nephropathy and Hints for its Possible Prevention by Drug Treatment. Anti-inflammatory & Anui-Allergy Agents in Medicinal Chemistry ,2006,5 : 139-146.
  • 5LissP, NygrenA, EriksonU, et al. Injection of low and isoosmolar contrast medium decreases oxygen tension in therenal medulla. Kidney Int, 1998,53 (3) :698-702.
  • 6BartorelliAL, MarenziG. Contrast Induced Nephropathy. Journal of Interventional Cardiology ,2008,21 ( 1 ) :74-85.
  • 7PotierM, LagroyeI, LakhdarB, et al. Comparative Cytotoxieity of Low-and High-Osmolar Contrast Media to Human Fibroblasts and Rat Mesangial Cells in Culture. Invest Radiol, 1997,32 ( 10 ) : 621-626.
  • 8MuellerC, BuerklG, BuettnerHJ, et al. Prevention of contrast media associated nephropathy:randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med ,2002,162:329-336.
  • 9MertenGJ, BrugessWP, GrayLV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA ,2004,291:2328-2334.

二级参考文献33

  • 1Murphy SW, Barrett BJ, Parfrey PS. Contrast nephrophathy. J Am Soci Nephrol, 2000,11:177-182.
  • 2Solomon R. Contrast-medium-induced acute renal failure. Kidney Int, 1998,53:230-242.
  • 3Porter GA, Kremer D. Contrast associated nephropathy:presentation,pathophysiology and management. In: De Broe ME, eds. Clinical nephrotoxins. Netherlands: Kluwer academic publishers, 1998.317-327.
  • 4Soma VR, Cavusoglu E, Vidhun R, et al. Contrast-Associated Nephropathy. Heart Disease, 2002,4:372-379.
  • 5Stouffer GA, Sheahan RG, Lenihan DJ, et al. Contrast Induced Nephropathy after Angiography. Am J Medical Sciences, 2002,323:252-258.
  • 6Asif A, Preston RA, Roth D. Radiocontrast-induced Nephropathy. Am J Ther, 2003,10:137-147.
  • 7Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA, 2003,289:553-558.
  • 8Durham JD, Caputo C, Dokko J, et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int, 2002,62:2202-2207.
  • 9Allaqaband S, Tumuluri R, Malik AM, et al. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv, 2002,57:279-283.
  • 10Tepel M, Vander GM, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med, 2002,343:180-184.

共引文献77

同被引文献19

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部